Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug resistance.
Theranostics
Vikova, Veronika V; Jourdan, Michel M; Robert, Nicolas N; Requirand, Guilhem G; Boireau, Stéphanie S; Bruyer, Angélique A; Vincent, Laure L; Cartron, Guillaume G; Klein, Bernard B; Elemento, Olivier O; Kassambara, Alboukadel A; Moreaux, Jérôme J
Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways.
Journal Of Hematology & Oncology
Tessoulin, Benoît B; Moreau-Aubry, Agnès A; Descamps, Géraldine G; Gomez-Bougie, Patricia P; Maïga, Sophie S; Gaignard, Alban A; Chiron, David D; Ménoret, Emmanuelle E; Le Gouill, Steven S; Moreau, Philippe P; Amiot, Martine M; Pellat-Deceunynck, Catherine C
Publication Date: 2018-12-13
Variant appearance in text: KMT2D: 4457G>A; Gly1486Asp
Mutational profile of primary breast diffuse large B-cell lymphoma.
Oncotarget
Franco, Fernando F; González-Rincón, Julia J; Lavernia, Javier J; García, Juan F JF; Martín, Paloma P; Bellas, Carmen C; Piris, Miguel A MA; Pedrosa, Lucia L; Miramón, José J; Gómez-Codina, José J; Rodríguez-Abreu, Delvys D; Machado, Isidro I; Illueca, Carmen C; Alfaro, Jesús J; Provencio, Mariano M; Sánchez-Beato, Margarita M